- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.02.2026 | 1.260 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 18.02.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.02.2026ISIN NameDE000A31C3Y4 ALTECH... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 18.02. | XFRA Q3I: AUSSETZUNG/SUSPENSION | 218 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILADDVISE GROUP AB... ► Artikel lesen | |
| 16.02. | ADDvise Group AB (publ): Resolutions at the extraordinary general meeting in ADDvise Group AB (publ) | 419 | GlobeNewswire (Europe) | At the extraordinary general meeting in ADDvise Group AB (publ) ("ADDvise") held today on 16 February 2026, Mia Tomczak and Richard Jernberg were elected as new board members of the company. The resolution... ► Artikel lesen | |
| 12.02. | ADDvise Group AB (publ): Year-end report 2025, January 1-December 31 | 310 | GlobeNewswire (Europe) | Increased profits, profitability and stable cash flow. In the fourth quarter, organic sales increased by 4.0% in constant currency and an increase of 1.5% for the full year 2025. Our focus on operational... ► Artikel lesen | |
| 03.02. | ADDvise Group AB (publ): Delisting of the shares and warrants in ADDvise from Nasdaq First North | 276 | GlobeNewswire (Europe) | On 29 January 2026, ADDvise Group AB (publ) ("ADDvise") announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market... ► Artikel lesen | |
| 29.01. | ADDvise Group AB (publ): ADDvise has applied for delisting of its shares and warrants from Nasdaq First North | 267 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex"), announced a public offer (the "Offer") to the holders of shares and warrants of ADDvise Group AB (publ) ("ADDvise"). On 27 January 2026, Amplex announced that... ► Artikel lesen | |
| 14.01. | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 251 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 259 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 468 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 239 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 485 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 413 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11.25 | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 245 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10.25 | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 252 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,170 | -2,15 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,540 | +0,47 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,540 | -2,51 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| INTUITIVE SURGICAL | 330,20 | -0,90 % | Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition? | ||
| UNITEDHEALTH | 329,80 | +0,79 % | Dividendenbekanntmachungen (14.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BROOKFIELD CORPORATION CA11271J1075 0,07 USD 0,0603 EUR BROOKFIELD WEALTH SOLUTIONS LTD BMG174341047 0,07 USD 0,0603 EUR CALAMOS... ► Artikel lesen | |
| MEDTRONIC | 80,24 | -0,62 % | Bis zu 5,4 Millionen US-Dollar pro Patient: Warum Medtronic, Globus Medical und NurExone an derselben Verletzung ansetzen | ||
| THERMO FISHER | 568,20 | +0,50 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| TELADOC HEALTH | 5,614 | +0,07 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,900 | +1,97 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| BICO GROUP | 2,010 | +6,35 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 76,42 | +2,38 % | Eurofins: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BECTON DICKINSON | 160,05 | +0,95 % | Waters Corporation: Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer | Enables routine 50+ parameter experiments with BD SpectralFX Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.Minimizes instrument and user differences... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 133,10 | +1,45 % | Should You Continue to Hold ALGN Stock in Your Portfolio? | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| INMODE | 12,640 | -0,59 % | InMode slips as unsolicited takeover offer from M.N. Business Strategy expires |
ADDVISE GROUP AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,142 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.